1. Deutschman CS，Tracey KJ.Sepsis：current dogma and new perspectives.Immunity.2014；40（4）：463-475.

2. Brealey D，Brand M，Hargreaves I，et al.Association between mitochondrial dysfunction and severity and outcome of septic shock.Lancet.2002；360（9328）：219-223.

3. Brealey D，Karyampudi S，Jacques TS，et al.Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure.Am J Physiol Regul Integr Comp Physiol.2004；286 （3）：R491-497.

4. Duvigneau JC，Piskernik C，Haindl S，et al.A novel endotoxin-induced pathway：upregulation of heme oxygenase 1，accumulation of free iron，and free iron-mediated mitochondrial dysfunction.Lab Invest.2008；88（1）：70-77.

5. Levy RJ，Vijayasarathy C，Raj NR，et al. Competitive and noncompetitive inhibition of myocardial cytochrome C oxidase in sepsis.Shock.2004；21（2）：110-114.

6. Langley RJ，Tsalik EL，van Velkinburgh JC et al.An integrated clinico-metabolomic model improves prediction of death in sepsis.Sci Transl Med.2013；5（195）：195ra95.

7. Fredriksson K，Tjäder I，Keller P，et al.Dysregulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failure. PLoS One.2008；3（11）：e3686.

8. Lee I，Hüttemann M.Energy crisis：the role of oxidative phosphorylation in acute inflammation and sepsis. Biochim Biophys Acta.2014；1842（9）：1579-1586.

9. Baudouin SV，Saunders D，Tiangyou W，et al.Mitochondrial DNA and survival after sepsis：a prospective study.Lancet. 2005 Dec 17；366（9503）：2118-21.

10. Lorente L，Martín MM，López-Gallardo E，et al.Platelet cytochrome c oxidase activity and quantity in septic patients. Crit Care Med.2011；39（6）：1289-94.

11. Gómez-Durán A，Pacheu-Grau D，López-Gallardo E，et al. Unmasking the causes of multifactorial disorders：OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet.2010；19（17）：3343-53.

12. Fetterman JL，Zelickson BR，Johnson LW，et al.Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload. Biochem J. 2013；455（2）：157-67.

13. Callahan LA，Supinski GS. Downregulation of diaphragm electron transport chain and glycolytic enzyme gene expression in sepsis.J Appl Physiol.2005；99（3）：1120-6.

14. Eyenga P，Roussel D，Morel J，et al.Early septic shock induces loss of oxidative phosphorylation yield plasticity in liver mitochondria.J Physiol Biochem.2014；70（2）：285-96.

15. Lu SM，Song SM，Liu JC，et al.Changes of proton transportation across the inner mitochondrial membrane and H（+）-ATPase in endotoxic shock rats.Chin J Traumatol.2003；6 （5）：292-6.

16. Newham P，Ross D，Ceuppens P，et al.Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α（TNF-α）using AZD9773，an anti-TNF-α immune Fab，in murine CLP sepsis.Inflamm Res.2014；63 （2）：149-60.

17. Li L，Hu BC，Chen CQ，et al.Role of mitochondrial damage during cardiac apoptosis in septic rats.Chin Med J（Engl）. 2013；126（10）：1860-1866.

18. Piel DA，Deutschman CS，Levy RJ.Exogenous cytochrome C restores myocardial cytochrome oxidase activity into the late phase of sepsis.Shock.2008；29（5）：612-6.

19. Samavati L，Lee I，Mathes I，et al.Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase.J Biol Chem.2008；283（30）：21134-44.

20. Covian R，Balaban RS.Cardiac mitochondrial matrix and respiratory complex protein phosphorylation. Am J Physiol Heart Circ Physiol.2012；303（8）：H940-66.

21. Supinski GS，Callahan LA.Double-stranded RNA-dependent protein kinase activation modulates endotoxin-induced diaphragm weakness.J Appl Physiol（1985）.2011；110（1）：199-205.

22. Supinski GS，Ji X，Callahan LA.The JNK MAP kinase pathway contributes to the development of endotoxin-induced diaphragm caspase activation. Am J Physiol Regul Integr Comp Physiol.2009；297（3）：R825-34.

23. Hanawa N，Shinohara M，Saberi B，et al.Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury.J Biol Chem.2008；283（20）：13565-77.

24. Chambers JW，Howard S，LoGrasso PV.Blocking c-Jun N-terminal kinase（JNK）translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity in vitro and in vivo.J Biol Chem.2013；288（2）：1079-87.

25. Neviere R，Hassoun SM，Decoster B，et al.Caspase-dependent protein phosphatase 2A activation contributes to endotoxin-induced cardiomyocyte contractile dysfunction. Crit Care Med.2010；38（10）：2031-2036.

26. Kim TY，Wang D，Kim AK，et al.Metabolic labeling reveals proteome dynamics of mouse mitochondria. Mol Cell Proteomics.2012；11（12）：1586-1594.

27. Rocha M，Herance R，Rovira S，et al.Mitochondrialdysfunction and antioxidant therapy in sepsis. Infect Disord Drug Targets.2012；12（2）：161-178.

28. Galley HF.Oxidative stress andmitochondrial dysfunction in sepsis.Br J Anaesth.2011；107：57-64.

29. Yang Y，Karakhanova S，Soltek S，et al.In vivo immunoregulatoryproperties of the novel mitochondria-targeted antioxidant SkQ1.Mol Immunol.2012；52（1）：19-29.

30. Sena LA，Li S，Jairaman A，et al.Mitochondria are requiredfor antigen-specific T cell activation through reactive oxygen species signaling.Immunity.2013；38（2）：225-236.

31. Zmijewski JW，Lorne E，Banerjee S，et al. Participation ofmitochondrial respiratorycomplex III in neutrophil activation and lung injury.Am J Physiol LungCell Mol Physiol. 2009；296（4）：L624-L634.

32. Kong X，Thimmulappa R，Kombairaju P，et al.NADPH oxidase-dependent reactiveoxygen species mediate amplified TLR4 signaling and sepsis-induced mortalityin Nrf2-deficient mice.J Immunol.2010；185（1）：569-577.

33. Dare AJ，Phillips AR，Hickey AJ，et al.A systematic review of experimental treatments for mitochondrial dysfunction insepsis and multiple organ dysfunction syndrome.Free Radic Biol Med.2009；47（11）：1517-1525.

34. Choi HM，Jo SK，Kim SH，et al.Glucocorticoids attenuate septic acute kidney injury.BiochemBiophys Res Commun. 2013；435（4）：678-684.